Altum Sequencing
1 known investors
Find your way into Altum Sequencing
156 people in our graph share verified history with the Altum Sequencing team — schools, employers, funds. One of them is your warm intro.
Gisella de la Rochaunlockedknows Joaquín Martínez · together at University of Toronto (overlapped)
×4knows the team · via University of Toronto
×7knows the team · via Universidad de Granada
Altum Sequencing develops molecular sequencing assays for oncology programs, supporting pharmaceutical companies and healthcare providers in biomarker strategy, companion diagnostic development, and post-approval patient monitoring in cancer treatment.
Founders & leadership
JM
Joaquín MartínezinChairman and Co-FounderA hematologist and professor of medicine at Universidad Complutense de Madrid and head of the Medical Oncology Department at Hospital Universitario 12 de Octubre, Martínez co-founded Altum Sequencing to develop molecular diagnostics and disease monitoring approaches in oncology.
Investors · 1
In the news
Frequently asked questions
- What does Altum Sequencing do?
- Altum Sequencing develops molecular sequencing assays for oncology programs, supporting pharmaceutical companies and healthcare providers in biomarker strategy, companion diagnostic development, and post-approval patient monitoring in cancer treatment.
- Who founded Altum Sequencing?
- Altum Sequencing was founded by Joaquín Martínez.
- Who are Altum Sequencing's investors?
- Altum Sequencing's investors include Ship2B.